T1	Participants 624 650	Women (8,800), aged 30-62,
T2	Participants 809 994	800 were offered a high-risk HPV self-test, 4,000 were randomized to a telephone call (reported previously) and 4,000 constituted a control group (standard screening invitation routine)
